The Thr190 residue is a licensing checkpoint for RIPK1 kinase activation and cytotoxicity

Abstract Receptor-interacting protein kinase 1 (RIPK1) dictates the balance between TNF-induced cell survival and death. Among the phosphorylation-dependent checkpoints that restrain RIPK1, threonine 190 (T190) is mechanistically unique: both phospho-deficient and phospho-mimetic mutations abolish kinase activity, indicating that the unmodified residue itself is required for RIPK1 activation. Despite this biochemical insight, the physiological relevance of T190 has remained unexplored due to the absence of an in vivo genetic model. To address this gap, we generated Ripk1 T190A/T190A knock-in mice. We show that the T190A mutation selectively abolishes RIPK1-dependent apoptosis, necroptosis, and pyroptosis, confers strong protection against TNF-induced systemic inflammatory response syndrome (SIRS), and fully rescues the embryonic lethality of Tbk1 −/− mice. Mechanistically, T190A specifically blocks RIPK1 autophosphorylation at Ser166, establishing T190 as a non-redundant licensing checkpoint that fundamentally distinguishes it from conventional inhibitory phosphorylation sites.

Authors

Institutions

Publication Details

Journal
Cell Death and Disease
Published
2026-11-17
DOI
https://doi.org/10.1038/s41419-026-09409-2
Primary Topic
Cell death mechanisms and regulation
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

The Thr190 residue is a licensing checkpoint for RIPK1 kinase activation and cytotoxicity

Chenglong Wang, Daichao Xu, Sisi Luan, Yuanxin Yang
Cell Death and Disease
Cell death mechanisms and regulation
article

The Thr190 residue is a licensing checkpoint for RIPK1 kinase activation and cytotoxicity

Chenglong Wang, Daichao Xu, Sisi Luan, Yuanxin Yang
article en

Abstract

Abstract Receptor-interacting protein kinase 1 (RIPK1) dictates the balance between TNF-induced cell survival and death. Among the phosphorylation-dependent checkpoints that restrain RIPK1, threonine 190 (T190) is mechanistically unique: both phospho-deficient and phospho-mimetic mutations abolish kinase activity, indicating that the unmodified residue itself is required for RIPK1 activation. Despite this biochemical insight, the physiological relevance of T190 has remained unexplored due to the absence of an in vivo genetic model. To address this gap, we generated Ripk1 T190A/T190A knock-in mice. We show that the T190A mutation selectively abolishes RIPK1-dependent apoptosis, necroptosis, and pyroptosis, confers strong protection against TNF-induced systemic inflammatory response syndrome (SIRS), and fully rescues the embryonic lethality of Tbk1 −/− mice. Mechanistically, T190A specifically blocks RIPK1 autophosphorylation at Ser166, establishing T190 as a non-redundant licensing checkpoint that fundamentally distinguishes it from conventional inhibitory phosphorylation sites.

Cell Death and Disease
Beijing Tongren Hospital (CN), Capital Medical University (CN), Chinese Academy of Sciences (CN), Chinese Academy of Medical Sciences & Peking Union Medical College (CN), Plastic Surgery Hospital (CN), Shanghai Institute of Organic Chemistry (CN)
Cell death mechanisms and regulation
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon